It provides convincing evidence that demographic-specific functional templates improve functional neuroimaging studies that use hyperalignment. This study will be of interest to cognitive ...
Funding supports IND-enabling activities for Casma’s CSM-101, a first-in-class TRPML1 agonist targeting lysosomal dysfunction in genetically driven neurodegenerative diseasesCAMBRIDGE, ...
OnePlus phones are lauded for their extreme durability, fantastic battery life, and ultra-fast charging, along with an overall intuitive experience. There are tons of OS features that you can leverage ...
Bored Panda on MSN
43 times teachers watched karma catch up with their worst students
Some children may engage in aggressive behavior, which experts say is simply a byproduct of the environment in which they were raised. However, it does not exempt them from the consequences of their ...
Because that’s what the Mapparium at the Mary Baker Eddy Library is: a three-story tall, stained-glass globe that you walk through on a bridge, and it’s one of the most mind-bending experiences you ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest ...
Anyone who ever opened Keynote or PowerPoint and stared at a blank slide for longer than you’d like to admit, you’re not alone. The hardest part of building a presentation isn’t usually the idea. It’s ...
WILMINGTON, DE – March 10, 2026 – PRESSADVANTAGE – ...
An FDA risk review has cleared the way for canine freeze-dried plasma, a shelf-stable product that could expand transfusion options in emergencies. A freeze-dried plasma product for canine patients is ...
VANCOUVER, British Columbia & GRAPEVINE, Texas, March 10, 2026--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" or the "Company"), a commercial-stage biopharmaceutical company focused on ...
For two nine-year-olds from Marion County, West Virginia, the science project they presented on March 9, 2026 at the West Virginia State Science and Engineering Fair in Charleston, West Virginia was ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer's disease (AD) and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results